NCT01078376 - A Comparative Single-Dose Pharmacokinetic (PK) and Safety Study of Azilsartan Medoxomil in Children With Hypertension and in Healthy Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

July 31, 2013

Study Completion Date

September 30, 2013

Conditions

Hypertension

Interventions

DRUG

Azilsartan medoxomil (TAK-491)

Azilsartan medoxomil 80 mg, tablets, orally, one day only

DRUG

Azilsartan medoxomil (TAK-491)

Azilsartan medoxomil 20 mg to 60 mg (based on participant weight), tablets, orally, one day only

DRUG

Azilsartan medoxomil (TAK-491)

Azilsartan medoxomil 20 mg to 60 mg (based on participant weight), tablets, orally, one day only

DRUG

Azilsartan medoxomil (TAK-491)

Azilsartan medoxomil 0.66 mg/kg participant body weight, granules, reconstituted orally, one day only

Trial Locations (8)

Little Rock

Atlanta

Louisville

Toledo

Birmingham

Bristol

London

Manchester